Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR™ Peptide Enhanced Bone Graft in ...
Reoperation rates between cervical disc replacement and anterior cervical discectomy and fusion didn’t see significant differences in reoperation risks. However disc replacement had some advantage in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback